Find Grants for Higher Education

Find out if you qualify for verified grants for Higher Education. Discover your eligibility and key funding details for Higher Education from major foundations and government agencies.

$ 100 Trillion
Total Dollars Available

Limited Competition: Basic Instrumentation Grant (BIG) Program (S10 Clinical Trial Not Allowed)

Deadline: June 1, 2027


Opportunity Number: PAR-24-326

Agency: National Institutes of Health

Open Date: October 29, 2024

Close Date: June 1, 2027

Status: Posted

CFDA Numbers: 93.351, 93.859

Shared Instrumentation Grant (SIG) Program (S10 Clinical Trial Not Allowed)

Deadline: June 1, 2027


Opportunity Number: PAR-24-265

Agency: National Institutes of Health

Open Date: October 29, 2024

Close Date: June 1, 2027

Status: Posted

CFDA Numbers: 93.351, 93.286, 93.866, 93.242, 93.867, 93.859

Translational Neural Devices (R61/R33 - Clinical Trial Optional)

Deadline: January 28, 2027


Opportunity Number: PAR-25-053

Agency: National Institutes of Health

Open Date: October 29, 2024

Close Date: January 28, 2027

Status: Posted

CFDA Numbers: 93.853

Development of Biomarkers or Composite Biomarkers for Neurological and Neuromuscular Disorders (R61/R33 - Clinical Trial Optional)

Deadline: January 7, 2028


Opportunity Number: PAR-25-024

Agency: National Institutes of Health

Open Date: October 28, 2024

Close Date: January 7, 2028

Status: Posted

CFDA Numbers: 93.853, 93.866

Pilot Projects Investigating Understudied Proteins Associated with Rare Diseases (R03 Clinical Trial Not Allowed)

Deadline: November 16, 2027


Opportunity Number: PAR-25-122

Agency: National Institutes of Health

Open Date: October 28, 2024

Close Date: November 16, 2027

Status: Posted

CFDA Numbers: 93.121, 93.853, 93.173, 93.350, 93.855, 93.242

BRAIN Initiative: Brain Behavior Quantification and Synchronization- Next Generation Sensor Technology Development (U01 Clinical Trial Optional)

Deadline: June 15, 2027


Opportunity Number: RFA-MH-26-140

Agency: National Institutes of Health

Open Date: October 23, 2024

Close Date: June 15, 2027

Status: Posted

CFDA Numbers: 93.286, 93.173, 93.867, 93.213, 93.273, 93.853, 93.866, 93.242, 93.865

NIDCR Drug, Biologic, Device and/or Procedure Intervention Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required)

Deadline: January 6, 2028


Opportunity Number: PAR-25-057

Agency: National Institutes of Health

Open Date: October 23, 2024

Close Date: January 6, 2028

Status: Posted

CFDA Numbers: 93.121

Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Development and Validation of Model Systems to Facilitate Neurotherapeutic Discovery (R61/R33 Clinical Trial Not Allowed)

Deadline: October 20, 2027


Opportunity Number: PAR-25-060

Agency: National Institutes of Health

Open Date: October 22, 2024

Close Date: October 20, 2027

Status: Posted

CFDA Numbers: 93.853

Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Assay Development and Neurotherapeutic Agent Identification (R61/R33 Clinical Trial Not Allowed)

Deadline: October 20, 2027


Opportunity Number: PAR-25-059

Agency: National Institutes of Health

Open Date: October 22, 2024

Close Date: October 20, 2027

Status: Posted

CFDA Numbers: 93.853

NIDCD Early Career Research(ECR) Award (R21 Clinical Trial Optional)

Deadline: October 15, 2027


Opportunity Number: PAR-25-120

Agency: National Institutes of Health

Open Date: October 18, 2024

Close Date: October 15, 2027

Status: Posted

CFDA Numbers: 93.173

Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 Clinical Trial Not Allowed)

Deadline: October 14, 2026


Opportunity Number: PAR-25-074

Agency: National Institutes of Health

Open Date: October 15, 2024

Close Date: October 14, 2026

Status: Posted

CFDA Numbers: 93.394

Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH3 Clinical Trials Not Allowed)

Deadline: October 14, 2026


Opportunity Number: PAR-25-075

Agency: National Institutes of Health

Open Date: October 15, 2024

Close Date: October 14, 2026

Status: Posted

CFDA Numbers: 93.394

Data Coordinating Center for NCCIH Multi-Site Investigator-Initiated Clinical Trials of Mind and Body Interventions (Collaborative U24 Clinical Trial Required)

Deadline: July 14, 2026


Opportunity Number: PAR-24-276

Agency: National Institutes of Health

Open Date: October 15, 2024

Close Date: July 14, 2026

Status: Posted

CFDA Numbers: 93.213

Continuation or Revision of NIDCR Clinical Trial Planning and Implementation Cooperative Agreement (UH3 Clinical Trial Required)

Deadline: January 6, 2028


Opportunity Number: PAR-25-062

Agency: National Institutes of Health

Open Date: October 10, 2024

Close Date: January 6, 2028

Status: Posted

CFDA Numbers: 93.121

Interventions to expand cancer screening and preventive services to ADVANCE health in populations that experience health disparities (R01, Clinical Trial Required)

Deadline: January 7, 2027


Opportunity Number: PAR-25-098

Agency: National Institutes of Health

Open Date: October 10, 2024

Close Date: January 7, 2027

Status: Posted

CFDA Numbers: 93.399, 93.307, 93.121, 93.313

Revision Applications for Validation of Biomarker Assays Developed Through NIH-Supported Research Grants (R01 Clinical Trial Not Allowed)

Deadline: October 14, 2026


Opportunity Number: PAR-24-304

Agency: National Institutes of Health

Open Date: October 10, 2024

Close Date: October 14, 2026

Status: Posted

CFDA Numbers: 93.394

Occupational Safety and Health Education and Research Centers (T42)

Deadline: October 26, 2028


Opportunity Number: RFA-OH-25-002

Agency: Centers for Disease Control and Prevention - ERA

Open Date: October 7, 2024

Close Date: October 26, 2028

Status: Posted

CFDA Numbers: 93.262

Limited Competition: CCRP Initiative: Promoting a Basic Understanding of Chemical Threats to Skin (R34 Clinical Trial Not Allowed)

Deadline: January 7, 2028


Opportunity Number: PA-25-093

Agency: National Institutes of Health

Open Date: October 4, 2024

Close Date: January 7, 2028

Status: Posted

CFDA Numbers: 93.855, 93.846

Analytical Validation of a Candidate Biomarker for Neurological or Neuromuscular Disorders(U01 Clinical Trial Optional)

Deadline: June 22, 2026


Opportunity Number: PAR-25-050

Agency: National Institutes of Health

Open Date: October 2, 2024

Close Date: June 22, 2026

Status: Posted

CFDA Numbers: 93.853

Clinical Validation of a Candidate Biomarker for Neurological or Neuromuscular Disorders (U01 Clinical Trial Optional)

Deadline: June 22, 2026


Opportunity Number: PAR-25-055

Agency: National Institutes of Health

Open Date: October 2, 2024

Close Date: June 22, 2026

Status: Posted

CFDA Numbers: 93.853

Research Experiences and/or Mentoring Networks through Research Education to Enhance Clinician-Scientists' Participation in NIDCDs Research (R25 Clinical Trial Not Allowed)

Deadline: September 29, 2027


Opportunity Number: PAR-25-020

Agency: National Institutes of Health

Open Date: October 2, 2024

Close Date: September 29, 2027

Status: Posted

CFDA Numbers: 93.173

SEEDING CRITICAL ADVANCES FOR LEADING ENERGY TECHNOLOGIES WITH UNTAPPED POTENTIAL (SCALEUP) READY

Deadline: September 29, 2029


Opportunity Number: DE-FOA-0003467

Agency: Advanced Research Projects Agency Energy

Open Date: October 2, 2024

Close Date: September 29, 2029

Status: Posted

CFDA Numbers: 81.135

Blueprint Neurotherapeutics Network (BPN): Biologic-based Drug Discovery and Development for Disorders of the Nervous System (UG3/UH3 Clinical Trial Optional)

Deadline: August 18, 2027


Opportunity Number: PAR-24-293

Agency: National Institutes of Health

Open Date: October 1, 2024

Close Date: August 18, 2027

Status: Posted

CFDA Numbers: 93.121, 93.867, 93.279, 93.242, 93.113, 93.853, 93.273, 93.213, 93.866

Fundamental Research to Counter Weapons of Mass Destruction

Deadline: September 30, 2034


Opportunity Number: HDTRA1-25-S-0001

Agency: Defense Threat Reduction Agency

Open Date: October 1, 2024

Close Date: September 30, 2034

Status: Posted

CFDA Numbers: 12.351

NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed)

Deadline: September 7, 2027


Opportunity Number: PA-25-080

Agency: National Institutes of Health

Open Date: October 1, 2024

Close Date: September 7, 2027

Status: Posted

CFDA Numbers: 93.394, 93.867, 93.273, 93.859, 93.121, 93.310, 93.350, 93.853, 93.855, 93.233, 93.395, 93.837, 93.279, 93.393, 93.213, 93.172, 93.113, 93.846, 93.866, 93.838, 93.879, 93.839, 93.286, 93.399, 93.361, 93.242, 93.396, 93.840

×

Request Grant Writing Assistance from GTC 360° Advisors

Our expert team at GTC 360° Advisors can help develop your grant strategy, recruit partner organizations, write your full proposal, compile and manage your budgets, and help you submit a compelling and compliant proposal on time.